FDA Inspection 1200350 — The Center for Fertility & Gynecology
The FDA completed an inspection of The Center for Fertility & Gynecology on March 20, 2023 in Tarzana, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 20, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Tarzana, CA (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 12242 | 21 CFR 1271.55(c) | Name and personal info on accompanying records |